Clinical Trial Update: ABI-007 (Nab-Paclitaxel) and Gemcitabine in Treating Women With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 study of nab-paclitaxel in combination with gemcitabine in women with metastatic breast cancer has completed enrollment and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: Mayo Clinic | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2011-05-26